In this study, we found that Girdin silencing in hepatocellular carcinoma cells significantly inhibited the PI3K-Akt signaling pathway, suggesting that the PI3K-Akt signaling pathway mediates the regulatory effect of Girdin on hepatocellular carcinoma progression. Here, CCDC88A is linked to hepatocellular carcinoma.